Kalehua Capital Management LLC Quant / Systematic

Location: DALLAS, TX

CIK: 0002106181 · Show all filings

Period: Q4 2025 (Next →)

Filing Date: Feb 13, 2026

Total Value: $101M (100.0% shares, 0.0% debt)

Holdings (19)

BOXX Alpha Architect 1-3 Month Box Etf 26.3%

Value $26.56M Shares 230,787 Est. Cost $115.10 Unrealized —

XFOR X4 Pharmaceuticals Inc 14.7%

Value $14.89M Shares 3,722,840 Est. Cost $3.63 Unrealized 0.0%

SION Sionna Therapeutics Inc 8.0%

Value $8.108M Shares 197,072 Est. Cost $37.92 Unrealized 0.0%

RLAY Relay Therapeutics Inc 7.5%

Value $7.626M Shares 901,457 Est. Cost $7.14 Unrealized 0.0%

CMPS Compass Pathways Plc 5.6%

Value $5.656M Shares 819,692 Est. Cost $6.90 Unrealized —

PHVS Pharvaris NV 5.5%

Value $5.516M Shares 198,772 Est. Cost $24.09 Unrealized 0.0%

SEPN Septerna Inc 5.4%

Value $5.424M Shares 194,544 Est. Cost $23.88 Unrealized 0.0%

ORKA Oruka Therapeutics Inc 3.6%

Value $3.592M Shares 118,524 Est. Cost $27.86 Unrealized 0.0%

IKT Inhibikase Therapeutics Inc 3.5%

Value $3.587M Shares 1,750,000 Est. Cost $1.59 Unrealized 0.0%

ALLO Allogene Therapeutics Inc 3.5%

Value $3.488M Shares 2,546,129 Est. Cost $1.32 Unrealized 0.0%

LONA LeonaBio Inc 2.9%

Value $2.98M Shares 393,701 Est. Cost $4.58 Unrealized 0.0%

MLTX MoonLake Immunotherapeutics 2.3%

Value $2.316M Shares 175,734 Est. Cost $11.80 Unrealized 0.0%

ORIC Oric Pharmaceuticals Inc 2.2%

Value $2.185M Shares 267,059 Est. Cost $11.51 Unrealized 0.0%

VRCA Verrica Pharmaceuticals Inc 1.9%

Value $1.959M Shares 235,779 Est. Cost $5.54 Unrealized 0.0%

TYRA Tyra Biosciences Inc 1.9%

Value $1.958M Shares 74,465 Est. Cost $18.37 Unrealized 0.0%

SRZN Surrozen Inc 1.9%

Value $1.886M Shares 385,178 Est. Cost $16.18 Unrealized 0.0%

TNYA Tenaya Therapeutics Inc 1.4%

Value $1.423M Shares 2,000,000 Est. Cost $1.36 Unrealized 0.0%

KLRS Kalaris Therapeutics Inc 1.2%

Value $1.181M Shares 139,901 Est. Cost $6.39 Unrealized 0.0%

DMAC Diamedica Therapeutics Inc 0.8%

Value $759K Shares 95,359 Est. Cost $7.48 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BOXX	Alpha Architect 1-3 Month Box Etf	230,787	$26.56M	26.3%	$115.10	—	ALPHA ARCH 1-3	02072L565
XFOR	X4 Pharmaceuticals Inc	3,722,840	$14.89M	14.7%	$3.63	0.0%	COM NEW	98420X202
SION	Sionna Therapeutics Inc	197,072	$8.108M	8.0%	$37.92	0.0%	COM	829401108
RLAY	Relay Therapeutics Inc	901,457	$7.626M	7.5%	$7.14	0.0%	COM	75943R102
CMPS	Compass Pathways Plc	819,692	$5.656M	5.6%	$6.90	—	SPONSORED ADS	20451W101
PHVS	Pharvaris NV	198,772	$5.516M	5.5%	$24.09	0.0%	COM	N69605108
SEPN	Septerna Inc	194,544	$5.424M	5.4%	$23.88	0.0%	COM	81734D104
ORKA	Oruka Therapeutics Inc	118,524	$3.592M	3.6%	$27.86	0.0%	COM	687604108
IKT	Inhibikase Therapeutics Inc	1,750,000	$3.587M	3.5%	$1.59	0.0%	COM NEW	45719W205
ALLO	Allogene Therapeutics Inc	2,546,129	$3.488M	3.5%	$1.32	0.0%	COM	019770106
LONA	LeonaBio Inc	393,701	$2.98M	2.9%	$4.58	0.0%	COM	04746L203
MLTX	MoonLake Immunotherapeutics	175,734	$2.316M	2.3%	$11.80	0.0%	CLASS A ORD	61559X104
ORIC	Oric Pharmaceuticals Inc	267,059	$2.185M	2.2%	$11.51	0.0%	COM	68622P109
VRCA	Verrica Pharmaceuticals Inc	235,779	$1.959M	1.9%	$5.54	0.0%	COM SHS	92511W207
TYRA	Tyra Biosciences Inc	74,465	$1.958M	1.9%	$18.37	0.0%	COM	90240B106
SRZN	Surrozen Inc	385,178	$1.886M	1.9%	$16.18	0.0%	COM NEW	86889P208
TNYA	Tenaya Therapeutics Inc	2,000,000	$1.423M	1.4%	$1.36	0.0%	COM	87990A106
KLRS	Kalaris Therapeutics Inc	139,901	$1.181M	1.2%	$6.39	0.0%	COM	482929106
DMAC	Diamedica Therapeutics Inc	95,359	$759K	0.8%	$7.48	0.0%	COM NEW	25253X207